BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11750838)

  • 1. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate.
    Dooley MJ; Poole SG; Rischin D; Webster LK
    Eur J Cancer; 2002 Jan; 38(1):44-51. PubMed ID: 11750838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H; Nagatomo A; Kunitoh H; Kunikane H; Watanabe K
    Cancer Chemother Pharmacol; 1998; 42(4):307-12. PubMed ID: 9744776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
    Nagao S; Fujiwara K; Imafuku N; Kagawa R; Kozuka Y; Oda T; Maehata K; Ishikawa H; Koike H; Aotani E; Kohno I
    Gynecol Oncol; 2005 Nov; 99(2):327-33. PubMed ID: 16005943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A; McCune JS; Faucette S; Gillenwater HH; Kowalski RJ; Socinski MA; Lindley C
    Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma.
    Shepherd ST; Gillen G; Morrison P; Forte C; Macpherson IR; White JD; Mark PB
    Eur J Cancer; 2014 Mar; 50(5):944-52. PubMed ID: 24445148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.
    Cathomas R; Klingbiel D; Geldart TR; Mead GM; Ellis S; Wheater M; Simmonds P; Nagaraj N; von Moos R; Fehr M
    Ann Oncol; 2014 Aug; 25(8):1591-7. PubMed ID: 24669017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies.
    de Lemos ML; Hsieh T; Hamata L; Levin A; Swenerton K; Djurdjev O; Vu T; Hu F; Conklin J; Malfair Taylor SC
    Gynecol Oncol; 2006 Dec; 103(3):1063-9. PubMed ID: 16875719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.
    Morrow A; Garland C; Yang F; De Luna M; Herrington JD
    J Oncol Pharm Pract; 2019 Oct; 25(7):1651-1657. PubMed ID: 30336729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flat dosing of carboplatin is justified in adult patients with normal renal function.
    Ekhart C; de Jonge ME; Huitema AD; Schellens JH; Rodenhuis S; Beijnen JH
    Clin Cancer Res; 2006 Nov; 12(21):6502-8. PubMed ID: 17085665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia.
    Herrington JD; Tran HT; Riggs MW
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):241-7. PubMed ID: 16133538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extension of the Calvert formula to patients with severe renal insufficiency.
    Oguri T; Shimokata T; Ito I; Yasuda Y; Sassa N; Nishiyama M; Hamada A; Hasegawa Y; Ando Y
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):53-9. PubMed ID: 25957958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
    Holweger K; Lipp HP; Beijnen JH; Bokemeyer C; Hartmann JT
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):693-701. PubMed ID: 21136060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma.
    Quinton A; Lewis P; Ali P; Morgan C; Bertelli G
    Med Oncol; 2013; 30(3):661. PubMed ID: 23864250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods.
    Huitema AD; Mathôt RA; Tibben MM; Schellens JH; Rodenhuis S; Beijnen JH
    Clin Pharmacol Ther; 2000 Jun; 67(6):621-30. PubMed ID: 10872644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients.
    Ainsworth NL; Marshall A; Hatcher H; Whitehead L; Whitfield GA; Earl HM
    Ann Oncol; 2012 Jul; 23(7):1845-53. PubMed ID: 22104575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer Institute.
    Millward MJ; Webster LK; Toner GC; Bishop JF; Rischin D; Stokes KH; Johnston VK; Hicks R
    Aust N Z J Med; 1996 Jun; 26(3):372-9. PubMed ID: 8811211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
    Ekhart C; Rodenhuis S; Schellens JH; Beijnen JH; Huitema AD
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):115-22. PubMed ID: 18989671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of formulas using the serum creatinine level to calculate the optimal dosage of carboplatin.
    van Warmerdam LJ; Rodenhuis S; ten Bokkel Huinink WW; Maes RA; Beijnen JH
    Cancer Chemother Pharmacol; 1996; 37(3):266-70. PubMed ID: 8529288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
    Bretagne M; Jouinot A; Durand JP; Huillard O; Boudou Rouquette P; Tlemsani C; Arrondeau J; Sarfati G; Goldwasser F; Alexandre J
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):45-53. PubMed ID: 28508095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer.
    Shimokata T; Ando Y; Yasuda Y; Hamada A; Kawada K; Saito H; Matsuo S; Kondo M; Imaizumi K; Hasegawa Y
    Cancer Sci; 2010 Dec; 101(12):2601-5. PubMed ID: 20860621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.